1. Home
  2. HUDI vs XLO Comparison

HUDI vs XLO Comparison

Compare HUDI & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huadi International Group Co. Ltd.

HUDI

Huadi International Group Co. Ltd.

N/A

Current Price

$0.77

Market Cap

11.5M

Sector

Industrials

ML Signal

N/A

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.81

Market Cap

56.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUDI
XLO
Founded
1998
2016
Country
China
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
56.9M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
HUDI
XLO
Price
$0.77
$8.81
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
80.6K
9.5K
Earning Date
01-30-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$43,766,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$168.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
589.88
52 Week Low
$0.66
$0.46
52 Week High
$2.02
$9.90

Technical Indicators

Market Signals
Indicator
HUDI
XLO
Relative Strength Index (RSI) 43.64 48.42
Support Level $0.71 $8.52
Resistance Level $0.98 $9.22
Average True Range (ATR) 0.05 0.29
MACD -0.01 -0.03
Stochastic Oscillator 20.10 57.33

Price Performance

Historical Comparison
HUDI
XLO

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: